Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Phase II Study of Stereotactic Radiosurgery or Other Local Ablation Followed by Erlotinib for Patients With Epidermal Growth Factor Receptor(EGFR) Mutation Who Have Previously Progressed on an Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
Status: Enrolling
Updated:  3/27/2018
Swedish Cancer Institute
mi
from
Seattle, WA
Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Phase II Study of Stereotactic Radiosurgery or Other Local Ablation Followed by Erlotinib for Patients With Epidermal Growth Factor Receptor(EGFR) Mutation Who Have Previously Progressed on an Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
Status: Enrolling
Updated: 3/27/2018
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer
Presurgical Phase IIB Trial of Oral CDB-4124 vs. Placebo in Women With Stage I-II Primary Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Northwestern University
mi
from
Chicago, IL
Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer
Presurgical Phase IIB Trial of Oral CDB-4124 vs. Placebo in Women With Stage I-II Primary Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
EValuation of Erlotinib as a Neoadjuvant Therapy in Stage III NSCLC Patients With EGFR Mutations (EVENT Trial)
Status: Enrolling
Updated:  3/27/2018
Albert Einstein College of Medicine
mi
from
Bronx, NY
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
EValuation of Erlotinib as a Neoadjuvant Therapy in Stage III NSCLC Patients With EGFR Mutations (EVENT Trial)
Status: Enrolling
Updated: 3/27/2018
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
EValuation of Erlotinib as a Neoadjuvant Therapy in Stage III NSCLC Patients With EGFR Mutations (EVENT Trial)
Status: Enrolling
Updated:  3/27/2018
Columbia University Medical Center
mi
from
New York, NY
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
EValuation of Erlotinib as a Neoadjuvant Therapy in Stage III NSCLC Patients With EGFR Mutations (EVENT Trial)
Status: Enrolling
Updated: 3/27/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
EValuation of Erlotinib as a Neoadjuvant Therapy in Stage III NSCLC Patients With EGFR Mutations (EVENT Trial)
Status: Enrolling
Updated:  3/27/2018
Weill-Cornell Medical College
mi
from
New York, NY
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
EValuation of Erlotinib as a Neoadjuvant Therapy in Stage III NSCLC Patients With EGFR Mutations (EVENT Trial)
Status: Enrolling
Updated: 3/27/2018
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
A Pilot Study to Determine the Biological Effects of Hydroxychloroquine on PAR-4 Levels in Patients With Resectable Solid Tumors
Status: Enrolling
Updated:  3/27/2018
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
A Pilot Study to Determine the Biological Effects of Hydroxychloroquine on PAR-4 Levels in Patients With Resectable Solid Tumors
Status: Enrolling
Updated: 3/27/2018
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Jefferson Clinic
mi
from
Birmingham, AL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Jefferson Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
UAB Comprehensive Cancer Center-LNB 301
mi
from
Birmingham, AL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
UAB Comprehensive Cancer Center-LNB 301
mi
from
Birmingham, AL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Providence Alaska Medical Center
mi
from
Anchorage, AK
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Providence Alaska Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
The University of California, San Diego
mi
from
La Jolla, CA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of California-Davis
mi
from
Sacramento, CA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
The Whittingham Cancer Center, Norwalk Hospital
mi
from
Norwalk, CT
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
The Whittingham Cancer Center, Norwalk Hospital
mi
from
Norwalk, CT
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Miami School of Medicine
mi
from
Miami, FL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Georgia Cancer Specialists
mi
from
Tucker, GA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Georgia Cancer Specialists
mi
from
Tucker, GA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Mercy Hospital and Medical Center
mi
from
Chicago, IL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Mercy Hospital and Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Chicago Medical Center
mi
from
Chicago, IL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Loyola University Medical Centre
mi
from
Maywood, IL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Loyola University Medical Centre
mi
from
Maywood, IL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Trinity Medical Center
mi
from
Moline, IL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Trinity Medical Center
mi
from
Moline, IL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Mid-Illinois Hematology & Oncology Associates, Ltd
mi
from
Normal, IL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Mid-Illinois Hematology & Oncology Associates, Ltd
mi
from
Normal, IL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Carle Cancer Centre
mi
from
Urbana, IL
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Carle Cancer Centre
mi
from
Urbana, IL
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Indiana University Medical Center
mi
from
Indianapolis, IN
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Maine Center for Cancer Medicine and Blood Disorders
mi
from
Scarborough, ME
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Maine Center for Cancer Medicine and Blood Disorders
mi
from
Scarborough, ME
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Suburban Hospital Cancer Program
mi
from
Bethesda, MD
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Suburban Hospital Cancer Program
mi
from
Bethesda, MD
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Medstar Health Research Institute
mi
from
Hyattsville, MD
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Medstar Health Research Institute
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Hutzel Women's Health Specialists
mi
from
Detroit, MI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Hutzel Women's Health Specialists
mi
from
Detroit, MI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
William Beaumont Hospital
mi
from
Royal Oak, MI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Kinston Medical Specialists
mi
from
Kinston, NC
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Kinston Medical Specialists
mi
from
Kinston, NC
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Cincinnati, Barrett Cancer Centre
mi
from
Cincinnati, OH
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Cincinnati, Barrett Cancer Centre
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Oklahoma
mi
from
Oklahoma City, OK
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Abramson Cancer Center of the
mi
from
Philadelphia, PA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Abramson Cancer Center of the
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Univ. of Wisconsin Center for Women's Health and
mi
from
Madison, WI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Univ. of Wisconsin Center for Women's Health and
mi
from
Madison, WI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
BCCA - Cancer Centre for the Southern Interior
mi
from
Kelowna,
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
BCCA - Cancer Centre for the Southern Interior
mi
from
Kelowna,
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
George Washington University
mi
from
Washington,
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Montefiore Medical Center
mi
from
Bronx, NY
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer
An Exploratory Study Evaluating FDG-PET as a Predictive Marker for mTOR Directed Therapy With RAD001 in Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  3/27/2018
University of Chicago
mi
from
Chicago, IL
Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer
An Exploratory Study Evaluating FDG-PET as a Predictive Marker for mTOR Directed Therapy With RAD001 in Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 3/27/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer
An Exploratory Study Evaluating FDG-PET as a Predictive Marker for mTOR Directed Therapy With RAD001 in Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  3/27/2018
Oncology/Hematology Associates
mi
from
Peoria, IL
Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer
An Exploratory Study Evaluating FDG-PET as a Predictive Marker for mTOR Directed Therapy With RAD001 in Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 3/27/2018
Oncology/Hematology Associates
mi
from
Peoria, IL
Click here to add this to my saved trials